National Bank of Canada
ABBV icon

National Bank of Canada’s AbbVie ABBV Stock Holding History

National Bank of Canada’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,090
Closed -$52.6M – 2727
2024
Q2 		$52.6M Buy
+3,090
New +$512K 0.07% 220

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

National Bank of Canada's ABBV Position: Q2 2026 in Review

National Bank of Canada reduced its AbbVie (ABBV) stake by 8.2% in Q2 2026, selling an estimated $16.4M and leaving 850,973 shares worth $214M. The position accounts for 0.15% of the portfolio, ranked #121.

National Bank of Canada first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $442M in Q3 2025. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • National Bank of Canada held 850,973 shares of AbbVie worth $214M as of Q2 2026.
  • National Bank of Canada sold 76,163 AbbVie shares in Q2 2026, an estimated $16.4M.
  • AbbVie made up 0.15% of National Bank of Canada's portfolio in Q2 2026, its #121 holding.
  • National Bank of Canada first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's AbbVie position peaked at $442M in Q3 2025.
  • 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.